Gsk (GLAXF) Gross Margin (2009 - 2026)

Gsk's Gross Margin history runs 18 years deep, the most recent figure standing at 75.42% for Q1 2026.

• In Q1 2026, Gross Margin rose 119.0% year-over-year to 75.42%; the TTM figure through Mar 2026 stood at 72.69% (down 1.0% YoY), while the FY2025 annual figure was 72.4%, up 123.0% from the prior year.
• Gross Margin was 75.42% for Q1 2026 at Gsk, up from 69.17% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 75.42% in Q1 2026 to a low of 62.21% in Q1 2022.
• Historically, Gross Margin has averaged 71.17% across 5 years, with a median of 72.57% in 2023.
• The sharpest annual moves came in 2022 and 2023: Gross Margin tumbled 570 bps in 2022, then surged 984 bps in 2023.
• A 5-year view of Gross Margin shows it stood at 65.34% in 2022, then increased by 11 bps to 72.57% in 2023, then grew by 1 bps to 73.16% in 2024, then dropped by 5 bps to 69.17% in 2025, then increased by 9 bps to 75.42% in 2026.
• The last three Gross Margin figures came in at 75.42% (Q1 2026), 69.17% (Q4 2025), and 73.58% (Q3 2025), per Business Quant data.